Top 10 Companies in the Pharmaceutical Hydrocolloids Market (2026): Market Leaders Powering Global Therapeutics

MARKET INSIGHTS

Global pharmaceutical hydrocolloids market size was valued at USD 376 million in 2024 and is projected to grow from USD 401 million in 2025 to USD 574 million by 2031, exhibiting a CAGR of 6.4% during the forecast period.

Pharmaceutical hydrocolloids are water‑soluble polymers derived from natural sources that form viscous solutions or gels when hydrated. These functional ingredients play critical roles in drug formulation as stabilizers, thickeners, binders, and controlled‑release agents. Major product segments include seaweed hydrocolloids (carrageenan, agar), plant‑derived gums (arabic gum, pectin), microbial polysaccharides (xanthan gum), and gelatin.

The market growth is driven by expanding pharmaceutical production volumes (Global pharmaceutical market reached USD 1.47 trillion in 2022) and increasing demand for novel drug delivery systems. However, stringent regulatory requirements for excipient approval and fluctuating raw material costs present challenges. Leading players like DuPont and Cargill are investing in R&D to develop multifunctional hydrocolloid systems for next‑generation formulations, particularly in oral solid dosage forms which dominate the pharmaceutical sector.

Pharmaceutical Hydrocolloids Market – View in Detailed Research Report

🔟 1. DuPont de Nemours, Inc.

Headquarters: Wilmington, Delaware, USA
Key Offering: Pharmaceutical‑grade seaweed hydrocolloids, xanthan gum, and advanced excipient blends

DuPont’s long history in excipient science has positioned it as a trusted partner for global pharmaceutical manufacturers. The company’s recent expansion of its nutrition division has unlocked new opportunities for multi‑functional hydrocolloids that simultaneously enhance bioavailability and reduce manufacturing costs.

Sustainability & Growth Initiatives:

• Carbon‑neutral production of carrageenan and xanthan gum
• Investment in renewable energy for downstream processing
• Strategic partnerships with contract manufacturers in Asia‑Pacific

9️⃣ 2. Cargill, Incorporated

Headquarters: Minneapolis, Minnesota, USA
Key Offering: High‑purity xanthan gum, seaweed hydrocolloids, and specialty binders

Cargill leverages its global supply chain to provide consistent quality and competitive pricing. Recent R&D initiatives focus on engineered polysaccharides that deliver precise drug release profiles for biologics and biosimilars.

Sustainability & Growth Initiatives:

• Zero‑waste processing of seaweed feedstock
• Adoption of circular economy principles in raw‑material sourcing
• Expansion of the Cargill Bio‑Industrial Platform

8️⃣ 3. CP Kelco

Headquarters: Milwaukee, Wisconsin, USA
Key Offering: Gellan gum, modified starches, and specialty gelling agents

CP Kelco’s launch of gellan gum for controlled drug release showcases its commitment to innovative excipient solutions. The company also provides customized blends for oral solid dosage forms and topical preparations.

Sustainability & Growth Initiatives:

• Biodegradable packaging for hydrocolloid products
• Investment in sustainable aquaculture for carrageenan sourcing
• Collaboration with academic partners on next‑generation polysaccharides

7️⃣ 4. Ingredion Incorporated

Headquarters: Dublin, Ohio, USA
Key Offering: Modified celluloses, arabic gum, and functional binders

Ingredion’s focus on plant‑derived excipients aligns with the clean‑label trend in pharmaceuticals. The company’s recent partnership with Asian manufacturers expands its regional footprint and enhances supply‑chain resilience.

Sustainability & Growth Initiatives:

• Carbon‑offset program for global operations
• Use of renewable energy in manufacturing facilities
• Development of low‑water‑footprint processing technologies

6️⃣ 5. Kerry Group

Headquarters: Tralee, Ireland
Key Offering: Seaweed‑derived hydrocolloids and specialty gelling agents

Kerry’s 2023 launch of a carbon‑neutral hydrocolloid facility in Belgium underscores its commitment to sustainable production. The company supplies high‑purity excipients to both pharmaceutical and nutraceutical markets.

Sustainability & Growth Initiatives:

• Carbon‑neutral production line for carrageenan
• Investment in marine conservation projects
• Expansion of the Kerry Green‑Supply Chain Initiative

5️⃣ 6. Royal DSM

Headquarters: Heerlen, Netherlands
Key Offering: Functional polysaccharides, gelatin, and specialty binders

Royal DSM’s focus on sustainable raw‑material sourcing and advanced biopolymer engineering positions it as a leader in the pharmaceutical excipient space.

Sustainability & Growth Initiatives:

• Zero‑emission manufacturing plants
• Biodegradable hydrocolloid formulations
• Strategic alliances with biotech firms for biologic excipients

4️⃣ 7. Ashland Global Holdings Inc.

Headquarters: Cleveland, Ohio, USA
Key Offering: Gelatin, modified starches, and specialty binders

Ashland’s expertise in protein‑based excipients supports the growing demand for biologic drug delivery systems.

Sustainability & Growth Initiatives:

• Recycling of gelatin by‑products
• Water‑efficient manufacturing processes
• Partnerships with animal‑welfare certification bodies

3️⃣ 8. FMC Corporation

Headquarters: St. Louis, Missouri, USA
Key Offering: Modified starches, xanthan gum, and specialty gelling agents

FMC’s focus on clean‑label excipients and its strong presence in the nutraceutical sector create synergies across pharmaceutical and functional‑food markets.

Sustainability & Growth Initiatives:

• Carbon‑neutral production of polysaccharides
• Investment in sustainable aquaculture for carrageenan
• Collaboration with research institutions on next‑generation hydrocolloids

2️⃣ 9. Dow Chemical Company

Headquarters: Midland, Michigan, USA
Key Offering: Gelatin, modified starches, and specialty binders

Dow’s strong R&D capabilities enable the development of high‑performance excipients for both conventional and advanced therapies.

Sustainability & Growth Initiatives:

• Water‑recycling initiatives in manufacturing sites
• Carbon‑neutral production of hydrocolloids
• Strategic partnerships with global contract manufacturers

1️⃣ 10. Evonik Industries AG

Headquarters: Essen, Germany
Key Offering: Functional polysaccharides, carrageenan, and specialty binders

Evonik’s focus on high‑performance polymers and its robust global distribution network support the growing demand for pharmaceutical excipients.

Sustainability & Growth Initiatives:

• Carbon‑neutral production of carrageenan
• Investment in renewable energy for downstream processing
• Partnerships with biopharma firms for biologic excipients

Download FREE Sample Report

Get Full Report

🌍 Outlook: The Future of Pharmaceutical Hydrocolloids Market

As the pharmaceutical industry continues to prioritize patient‑centric therapies, the demand for natural, high‑performance excipients is set to rise. Technological advancements in 3D printing, controlled‑release formulations, and biologic drug delivery are expected to drive the adoption of hydrocolloids across oral, topical, and injectable dosage forms. Regional dynamics will also play a key role, with Asia‑Pacific emerging as the fastest‑growing market due to its expanding generic drug sector and increasing focus on biologics.

📈 Key Trends Shaping the Market:

• Growth of plant‑based and seaweed‑derived hydrocolloids for clean‑label applications
• Expansion of 3D printing and additive manufacturing in pharmaceutical manufacturing
• Increased demand for hydrocolloids in biologics and biosimilar drug delivery
• Focus on sustainability and carbon‑neutral production across the supply chain
• Rise of multi‑functional excipients that serve both pharmaceutical and nutraceutical markets